Bank Of America Corp Opgen Inc Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.12 - $62.0 $12 - $6,200	-100 Reduced 38.17%	162 $0
Q3 2022 Nov 14, 2022	BUY	$0.39 - $78.8 $39 - $7,880	100 Added 61.73%	262 $0
Q1 2022 May 16, 2022	BUY	$0.72 - $1.11 $14 - $22	20 Added 14.08%	162 $0
Q4 2021 Feb 08, 2022	SELL	$1.0 - $2.94 $564 - $1,658	-564 Reduced 79.89%	142 $0
Q3 2021 Nov 15, 2021	BUY	$2.18 - $3.58 $1,190 - $1,954	546 Added 341.25%	706 $2,000
Q2 2021 Sep 13, 2021	BUY	$1.95 - $2.8 $312 - $448	160 New	160 $0

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.